Pluri (PLUR) Interest Expenses (2022 - 2025)

Pluri (PLUR) reported Interest Expenses of $231000.0 for Q4 2025, up 9.48% year-over-year from $211000.0 in Q4 2024, and up 0.87% quarter-over-quarter from $229000.0 in Q3 2025.

Pluri (PLUR) Interest Expenses (2022 - 2025) Analysis & Trends

Pluri (PLUR) has 4 years of Interest Expenses data on file, last reported at $231000.0 in Q4 2025.

  • Interest Expenses for Q4 2025 came in at $231000.0, up 9.48% year-over-year; the trailing twelve-month figure through Dec 2025 was $905000.0 (up 4.75% YoY), and the FY2025 annual result was $873000.0, up 0.81% from the prior year.
  • Interest Expenses grew to $231000.0 in Q4 2025 per PLUR's latest filing, from $229000.0 in the prior quarter.
  • Over five years, Interest Expenses peaked at $233000.0 in Q2 2025 and troughed at $194000.0 in Q3 2022.
  • A 4-year average of $217285.7 and a median of $217000.0 in 2023 frame the typical range for Interest Expenses.
  • The sharpest annual moves came in 2023 and 2025: Interest Expenses increased 10.31% in 2023, then retreated 2.75% in 2025.
  • A 4-year view of Interest Expenses shows it stood at $212000.0 in 2022, then advanced by 1.89% to $216000.0 in 2023, then fell by 2.31% to $211000.0 in 2024, then increased by 9.48% to $231000.0 in 2025.
  • Business Quant data shows PLUR's Interest Expenses at $231000.0 in Q4 2025, $229000.0 in Q3 2025, and $233000.0 in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int Expense (Qtr)
1 Alterity Therapeutics 719,706.53 Bn 719,706.50 Bn - -
2 Belite Bio 55,800.00 Bn 55,800.00 Bn - -
3 Quantum Biopharma 18,182.30 Bn 18,182.29 Bn - -
4 Legend Biotech 3,154.00 Bn 3,153.71 Bn 242.10 Mn -5.50 Mn
5 Akari Therapeutics 1,844.30 Bn 1,844.29 Bn - 61,000.00
6 Evaxion A 1,567.96 Bn 1,567.94 Bn - -332,000.00
7 Psyence Biomedical 251.43 Bn 251.42 Bn - -2,753.00
8 Vertex Pharmaceuticals 112.56 Bn 105.31 Bn 2.59 Bn -
9 Abivax 94.37 Bn 94.37 Bn - -5.58 Mn
10 Pluri 21.39 Mn 21.87 Mn 86,000.00 231,000.00

Historic Data

Download Data
DateValue
Dec 31, 2025 231,000.00
Dec 31, 2025 231,000.00
Sep 30, 2025 229,000.00
Sep 30, 2025 229,000.00
Jun 30, 2025 233,000.00
Jun 30, 2025 233,000.00
Mar 31, 2025 212,000.00
Mar 31, 2025 212,000.00
Dec 31, 2024 211,000.00
Dec 31, 2024 211,000.00
Sep 30, 2024 217,000.00
Sep 30, 2024 217,000.00
Jun 30, 2024 218,000.00
Jun 30, 2024 218,000.00
Mar 31, 2024 218,000.00
Mar 31, 2024 218,000.00
Dec 31, 2023 216,000.00
Dec 31, 2023 216,000.00
Sep 30, 2023 214,000.00
Sep 30, 2023 214,000.00